Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Patent CN111039767B reveals a metal-free route for deuterated aldehydes using triazole carbene, offering high deuteration rates and cost efficiency for pharmaceutical supply chains.
Patent CN110452150A reveals mild chiral phosphoric acid catalysis. Enables cost reduction in fine chemical intermediates manufacturing with high enantioselectivity.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.
Patent CN113354573A reveals a scalable route for alpha,alpha-terpyridine. Eliminate palladium residues and achieve 99.4% purity for optical and pharma applications.
Patent CN110467555B reveals a novel chiral phosphoric acid catalyzed method for synthesizing axially chiral indoles with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN107602577A details a novel organocatalytic route for chiral oxindole spiropiperidines. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN107936025B reveals a metal-free NHC catalytic route for high-purity chiral pyrazolidinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115232163B reveals a transition-metal-free NHC catalytic route for silicon-centered chiral compounds, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110746278B reveals a mild, non-metal route for 1,3-diketones. Achieve high purity and cost reduction in API manufacturing without precious metal catalysts.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN107936025B details a metal-free NHC catalytic route for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and scalable supply.
Patent CN108558882B reveals a novel [3+2] cycloaddition route for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.